Zai Lab Ltd
ZLAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001704292
In the last 90 days, Zai Lab Ltd insiders filed 1 open-market purchase and 4 sales; 92 institutions reported holding it in 13F filings for Q2 2026, worth $819.0M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Zai Lab Ltd as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 138
- −17 vs. Q2 2025
- Shares held
- 35.2M
- −7.44M (−17.5%) vs. Q2 2025
- Total value
- $1.19B
- −$298.1M (−20.0%) vs. Q2 2025
- New holders
- 21
- 48 more added
- Sold out
- 38
- 46 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZLAB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 92 | $819.0M |
| Q1 2026 | 99 | $530.9M |
| Q4 2025 | 126 | $510.5M |
| Q3 2025 | 138 | $1.19B |
| Q2 2025 | 156 | $1.49B |
| Q1 2025 | 160 | $1.97B |
| Q4 2024 | 131 | $1.48B |
| Q3 2024 | 104 | $1.09B |
| Q2 2024 | 105 | $702.4M |
| Q1 2024 | 117 | $659.7M |
| Q4 2023 | 124 | $1.12B |
| Q3 2023 | 122 | $954.6M |
| Q2 2023 | 138 | $1.19B |
| Q1 2023 | 161 | $1.76B |
| Q4 2022 | 167 | $1.78B |
| Q3 2022 | 171 | $2.03B |
| Q2 2022 | 166 | $2.09B |
| Q1 2022 | 176 | $2.71B |
| Q4 2021 | 207 | $4.06B |
| Q3 2021 | 228 | $6.76B |
| Q2 2021 | 234 | $11.0B |
| Q1 2021 | 222 | $7.24B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Zai Lab Ltd; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| IvyRock Asset Management (HK) Ltd | 94,879 | $3.22M | 1.38% | +94,879 | New |
| Principal Financial Group Inc | 104,285 | $3.53M | 0.00% | −228−0.2% | Reduced |
| Balyasny Asset Management LLC | 104,349 | $3.54M | 0.01% | +73,578+239.1% | Added |
| Mirae Asset Global Investments Co., Ltd. | 105,099 | $3.56M | 0.01% | +27,242+35.0% | Added |
| Morgan Stanley | 119,880 | $4.06M | 0.00% | −169,221−58.5% | Reduced |
| TD Asset Management Inc | 121,528 | $4.12M | 0.00% | +97,400+403.7% | Added |
| Privium Fund Management B.V. | 132,189 | $4.48M | 0.81% | 00.0% | Unchanged |
| LMR Partners LLP | 132,668 | $4.50M | 0.06% | +88,598+201.0% | Added |
| State Street Corp | 136,338 | $4.62M | 0.00% | −2,386−1.7% | Reduced |
| Bank of America Corp | 142,374 | $4.83M | 0.00% | −7,370−4.9% | Reduced |
| Northern Trust Corp | 146,003 | $4.95M | 0.00% | −140.0% | Reduced |
| Schroder Investment Management Group | 157,061 | $5.17M | 0.00% | +134,362+591.9% | Added |
| Hennion & Walsh Asset Management, Inc. | 160,037 | $5.42M | 0.20% | −8,053−4.8% | Reduced |
| Wells Fargo & Company | 175,132 | $5.94M | 0.00% | +652+0.4% | Added |
| Raymond James Financial Inc | 184,766 | $6.26M | 0.00% | −5,147−2.7% | Reduced |
| Woodline Partners LP | 198,509 | $6.73M | 0.03% | −1,002,507−83.5% | Reduced |
| Superstring Capital Management LP | 200,628 | $6.80M | 6.70% | +65,733+48.7% | Added |
| Envestnet Asset Management Inc | 252,030 | $8.54M | 0.00% | +12,783+5.3% | Added |
| Nan Fung Trinity (HK) Ltd | 269,975 | $9.15M | 0.91% | 00.0% | Unchanged |
| UBS Group AG | 306,554 | $10.4M | 0.00% | +64,904+26.9% | Added |
| Legal & General Group Plc | 382,459 | $13.0M | 0.00% | +300,623+367.3% | Added |
| B Group, Inc. | 400,000 | $13.6M | 12.96% | 00.0% | Unchanged |
| BlackRock, Inc. | 473,563 | $16.0M | 0.00% | +18,276+4.0% | Added |
| C WorldWide Group Holding A/S | 510,000 | $17.3M | 0.27% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 745,060 | $25.3M | 4.13% | 00.0% | Unchanged |
| Rock Springs Capital Management LP | 791,193 | $26.8M | 1.57% | −80,199−9.2% | Reduced |
| Allianz Asset Management GmbH | 815,000 | $27.6M | 0.03% | −117,000−12.6% | Reduced |
| ADAR1 Capital Management, LLC | 868,780 | $29.4M | 2.92% | +18,343+2.2% | Added |
| Price T Rowe Associates Inc | 948,671 | $32.2M | 0.00% | +795,634+519.9% | Added |
| Citadel Advisors LLC | 987,043 | $33.5M | 0.03% | +620,830+169.5% | Added |
| Bamco Inc | 1,371,243 | $46.5M | 0.12% | −216,571−13.6% | Reduced |
| Frazier Life Sciences Management, L.P. | 1,627,320 | $55.1M | 1.65% | +319,182+24.4% | Added |
| Wellington Management Group LLP | 1,718,455 | $58.2M | 0.01% | +341,492+24.8% | Added |
| Janus Henderson Group PLC | 2,049,537 | $69.5M | 0.03% | −148,323−6.7% | Reduced |
| RTW Investments, LP | 2,291,372 | $77.7M | 0.96% | −3,245,504−58.6% | Reduced |
| Clearbridge Investments, LLC | 3,519,337 | $119.3M | 0.09% | −492,619−12.3% | Reduced |
| FMR LLC | 4,701,711 | $159.3M | 0.01% | −1,495,712−24.1% | Reduced |
| Capital World Investors | 6,077,666 | $206.0M | 0.03% | +41,481+0.7% | Added |
| Jennison Associates LLC | 0 | $0 | 0.00% | −592,332−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −387,362−100.0% | Sold out |
| XY Capital Ltd | 0 | $0 | 0.00% | −362,627−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −252,400−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −250,438−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −238,897−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −232,900−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −231,000−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −158,254−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −97,273−100.0% | Sold out |
| Canada Pension Plan Investment Board | 0 | $0 | 0.00% | −87,500−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −74,193−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −66,003−100.0% | Sold out |
| AXA S.A. | 0 | $0 | 0.00% | −65,814−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −60,100−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −56,473−100.0% | Sold out |
| Keystone Investors Pte Ltd | 0 | $0 | 0.00% | −55,210−100.0% | Sold out |
| Public Employees Retirement System of Ohio | 0 | $0 | 0.00% | −23,820−100.0% | Sold out |
| Alberta Investment Management Corp | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| M&T Bank Corp | 0 | $0 | 0.00% | −21,825−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −20,978−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −13,949−100.0% | Sold out |
| National Philanthropic Trust | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Wealth Alliance | 0 | $0 | 0.00% | −5,821−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −5,250−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −2,092−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −873−100.0% | Sold out |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −713−100.0% | Sold out |
| Smithfield Trust Co | 0 | $0 | 0.00% | −531−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −400−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −3,785−100.0% | Sold out |
| Whittier Trust Co of Nevada Inc | 0 | $0 | 0.00% | −322−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −114−100.0% | Sold out |
| Riggs Asset Managment Co. Inc. | 0 | $0 | 0.00% | −76−100.0% | Sold out |
| Sierra Ocean, LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Brown Brothers Harriman & Co | 0 | $0 | 0.00% | −40−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −29−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Avantax Advisory Services, Inc. | – | – | – | – | Not filed |